Ebola – Hands on, ICPIC Pre-meeting workshop

Schermafbeelding 2015-04-07 om 12.25.10

Just before the start of ICPIC 2015

June 16, 2015 (10:00-16:50)

Field experiences with Ebola virus disease in West Africa (10:00-12:45)

Moderators : Prof. Benedetta Allegranzi ; Prof. Babacar Ndoye

1) Ebola epidemic in West Africa and WHO Ebola response roadmap (10:00)

Prof. Benedetta Allegranzi, WHO Patient Safety, WHO, Geneva

2) Using the core components of infection control programmes during the Ebola outbreak

Dr. Sergei Eremin, medical officer, WHO, Geneva (10:25)

3) Main lessons from Médecins-Sans-Frontières (MSF) engagement (10:50)

Hugues Robert, Médecins-Sans-Frontières (Doctors without Borders), MSF Switzerland

4) Ebola control in Guinea: the importance of interaction between physicians and

anthropologists (11:15)

Prof. Babacar Ndoye, Senegal and WHO/UNDP consultant in Africa

5) Engaging the community and community leaders (11:35)

Dr. Frederick Marais, South Africa

6) Coordinating the Ebola response in Sierra Leone: a UK perspective (11:55)

Donal Brown, Global Funds Department, UK Department for International Development; former Head of the UK Ebola taskforce in Sierra Leone.

7) Concrete field actions by the Swiss Government in West Africa (12:15)

Dr. Olivier Hagon, humanitarian assistance, Geneva

Final Q &A

Lunch break (12:45-13:15)

Understand, Control and Treat Ebola virus disease (13:15-16:50)

Experiences based on handling Ebola virus disease in Geneva, New York, Washington and Africa

Moderators : Prof. Laurent Kaiser; Prof. Claire-Anne Siegrist

1) What’s new about the diagnosis and treatment of Ebola virus? (13:15)

Prof. Laurent Kaiser, Virology and Infectious Diseases, Geneva

2) What are the complications of Ebola virus disease in survivors? (13:40)

Dr. Pauline Vetter, infectious disease fellow, Geneva

3) HIV and Ebola virus: two jumped species but not two of a kind? (14:00)

Prof. Alexandra Calmy, Head of HIV unit, Geneva

4) How different is it to treat Ebola in Sierra Leone versus Geneva? (14:20)

Dr. Manuel Schibler, infectious diseases physician, Geneva

5)What are the main lessons learned for infection control? (14:40)

Prof. Benedetta Allegranzi, WHO Patient Safety, WHO

6)  What are the challenges for the critical care physician? (15:05)

Prof. Jérôme Pugin, Head of Critical Care, Geneva

7) What were the difficulties in caring for a very critically ill Ebola patient at the National Institutes of Health Clinical Center in Washington? (15:30)

Dr. David Henderson, National Institutes of Health (NIH) Clinical Center, Washington DC

8) Where do we stand with Ebola vaccines? (15:55)

Prof. Claire-Anne Siegrist, Center for Vaccinology and WHO Collaborating centre for Vaccine Immunology, Geneva

Final round table discussion (16:20-16:50)

With the participation of all speakers and Dr Daniel Koch, Federal Office for Public Health, Switzerland, and Dr Anne Iten, Dr Michael Tapper, Prof Didier Pittet who have been in direct contact with the management of Ebola cases at field, hospital or public health levels in Africa, in Europe and in the USA.

-Perspectives on the financing of Ebola vaccines and approaches for their effective deployment.

Introduced by Donal Donal Brown, Global Funds Department, UK Department for International Development; board member of Gavi, the Vaccine Alliance (Gavi) and the Global Fund the Fight AIDS, Tuberculosis and Malaria.

-New horizons for the treatment of Ebola virus diseases in Africa and elsewhere.

Introduced by Laurent Kaiser, Head of Virology and Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine.

-Treatment of all Ebola virus diseases by world experts in state-of-the-art hospitals in Africa.

Introduced by Edward Kelley, Director, WHO Service Delivery & Safety, WHO, Geneva.

Faculty

Prof Benedetta Allegranzi, Team lead, Clean Care is Safer Care programme, WHO Service Delivery & Safety and Infection Prevention & Control for Ebola response, WHO, Geneva. Benedetta is involved in all activities associated with infection control in regards to Ebola virus disease and is conducting repeated missions in West Africa.

Donal Brown, Director of the Global Funds Department (GFD), UK Department for International Development (DFID), based in Geneva. Donal is a Board member of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance. Donal is the former Head of the UK Ebola taskforce in Sierra Leone. Donal led the UK civilian and military response to Ebola in Sierra Leone, coordinating the response at national and district level.

Prof Alexandra Calmy, Head of HIV Clinic, infectious diseases physician, University of Geneva Hospitals and Faculty of Medicine. Alexandra has been involved in clinical care of Ebola patients in Sierra Leone.

Dr Sergey Eremin, medical officer, WHO Pandemic and Epidemic Diseases, WHO, Geneva. Sergei has been one of the leaders of the Infection Prevention & Control team for the Ebola response and has been engaged in the development of WHO recommendations for Ebola infection control.

Dr Olivier Hagon, Medical director, humanitarian assistance, University of Geneva Hospitals. Olivier is engaged in humanitarian assistance and missions in Liberia and Guinea.

Dr David Henderson, Deputy Director for Clinical Care, National Institutes of Health (NIH) Clinical Center, Washington DC. David has provided executive leadership for a team that has provided care for four patients who were either exposed to, or suffering from Ebola virus disease at NIH, including a very sick, critically ill patient.

Dr Anne Iten, Infection Control physician, University of Geneva Hospitals (HUG). Anne has been involved with the development and adaptation of HUG infection control procedures and WHO guidance documents for Ebola control. Anne was involved in the management of an Ebola patient in Geneva.

Prof Laurent Kaiser, Head of Virology and Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine. Laurent has been involved in clinical care, and laboratory and clinical procedures associated with the management and treatment of an Ebola patient in Geneva, as well as missions in Liberia.

Dr Daniel Koch, medical officer, Federal Office for Public Health, Switzerland. Daniel is engaged in the evaluation of the preparedness of the Swiss hospitals and public health system to Ebola response.

Dr Frederick Marais, Western Cape government & Stellenbosch University, South Africa. Frederick and his research team have developed a “community protocol” to engage the community and community leaders in Ebola control.

Prof Babacar Ndoye, Dakar, Senegal. Expert in infection control and microbiology, and consultant for the WHO. Babacar eceived the mission to evaluate health-care systems in Guinea and Liberia, where he visited most hospitals and provided bedside expertise on Ebola control.

Prof Didier Pittet, Head of Infection Control and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine. Didier is involved in activities associated with the development of WHO guidelines and guidance documents for Ebola control. Didier was involved in the management of an Ebola patient in Geneva.

Prof Jérôme Pugin, Head of Critical Care, University of Geneva Hospitals and Faculty of Medicine. Jérôme has been the physician in charge of the patient with Ebola disease transferred from Sierra Leone to the University of Geneva Hospitals.

Hugues Robert, Emergency Program Manager, Médecins-Sans-Frontières (Doctors without Borders), MSF, Switzerland. Hugues is an expert of the management of complex emergencies for more than 10 years. Hugues is involved in the management of Ebola outbreak response in West Africa and has been engaged in several field missions.

Dr Manuel Schibler, virologist and infectious diseases physician, University of Geneva Hospitals. Manual has been involved in clinical care, and laboratory procedures associated with the management of Ebola patients in Geneva and Sierra Leone.

Prof Claire-Anne Siegrist, Centre for Vaccinology, University Hospitals of Geneva and WHO Collaborating centre for Vaccine Immunology. Professor of Medicine, Director of the Departement of Pediatrics at the University of Geneva, Claire-Anne is the principal investigator of the Ebola-VZV vaccine clinical trial.

Prof Michael Tapper, Director, Division of Infectious DiseasesLenox Hill Hospital, New York, USA. Michael is a member of the CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) which edited the CDC’s guidance documents on the care of suspect and confirmed Ebola patients in the USA. Michael also served as a member of the advisory group of the New York City Dep. of Health to advise on infection control challenges associated with the return of an Ebola infected physician from Liberia to New York City.

Dr Pauline Vetter, infectious disease fellow, University of Geneva Hospitals. Pauline has been involved in clinical care, laboratory, and infection control procedures associated with the management of Ebola patients in Geneva and in Africa.

posted by Andreas

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s